R DOUGLAS NORBY Insider Trading $ALXN ALEXION PHARMACEUTICALS, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for R DOUGLAS NORBY.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of R DOUGLAS NORBY. R DOUGLAS NORBY is Director in ALEXION PHARMACEUTICALS INC ($ALXN) and Director in MAGNACHIP SEMICONDUCTOR Corp ($MX) and Director in Krystal Biotech, Inc. ($KRYS).
R DOUGLAS NORBY in ALEXION PHARMACEUTICALS, INC.
Trading Symbol: ALXNIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of R DOUGLAS NORBY: Director
Holdings: 4,906 shares
Current Value: $626,594
Latest Transaction: May 12 2017
$ALXN Market Capitalization: $28.30B
$ALXN Previous Close: $127.72
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of R DOUGLAS NORBY in ALEXION PHARMACEUTICALS, INC.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALXN, KRYS, MX
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 12 2017 | ALXN | ALEXION PHARMACEUT ... | NORBY R DOUGLAS | Director | Grant | A | 0.00 | 2,030 | 0 | 4,906 | 2.9 K to 4.9 K (+70.58 %) |
Sep 27 2016 | ALXN | ALEXION PHARMACEUT ... | NORBY R DOUGLAS | Director | Sell | M | 131.97 | 1,774 | 234,115 | 2,876 | 4.7 K to 2.9 K (-38.15 %) |
Sep 27 2016 | ALXN | ALEXION PHARMACEUT ... | NORBY R DOUGLAS | Director | Sell | M | 131.10 | 3,724 | 488,216 | 4,650 | 8.4 K to 4.7 K (-44.47 %) |
Sep 27 2016 | ALXN | ALEXION PHARMACEUT ... | NORBY R DOUGLAS | Director | Sell | M | 130.03 | 2,800 | 364,084 | 8,374 | 11.2 K to 8.4 K (-25.06 %) |
Sep 27 2016 | ALXN | ALEXION PHARMACEUT ... | NORBY R DOUGLAS | Director | Sell | M | 128.81 | 7,202 | 927,690 | 11,174 | 18.4 K to 11.2 K (-39.19 %) |
May 13 2016 | ALXN | ALEXION PHARMACEUT ... | NORBY R DOUGLAS | Director | Option Exercise | A | 138.86 | 2,294 | 318,545 | 2,294 | |
May 13 2016 | ALXN | ALEXION PHARMACEUT ... | NORBY R DOUGLAS | Director | Grant | A | 0.00 | 835 | 0 | 18,376 | 17.5 K to 18.4 K (+4.76 %) |
Dec 15 2015 | ALXN | ALEXION PHARMACEUT ... | NORBY R DOUGLAS | Director | Sell | S | 188.24 | 9,833 | 1,850,964 | 32,481 | 42.3 K to 32.5 K (-23.24 %) |
Dec 15 2015 | ALXN | ALEXION PHARMACEUT ... | NORBY R DOUGLAS | Director | Sell | S | 187.57 | 35,575 | 6,672,803 | 42,314 | 77.9 K to 42.3 K (-45.67 %) |
Dec 15 2015 | ALXN | ALEXION PHARMACEUT ... | NORBY R DOUGLAS | Director | Sell | S | 186.97 | 34 | 6,357 | 77,889 | 77.9 K to 77.9 K (-0.04 %) |
Dec 15 2015 | ALXN | ALEXION PHARMACEUT ... | NORBY R DOUGLAS | Director | Grant | A | 96.35 | 3,425 | 329,999 | 77,923 | 74.5 K to 77.9 K (+4.60 %) |
Dec 15 2015 | ALXN | ALEXION PHARMACEUT ... | NORBY R DOUGLAS | Director | Grant | A | 85.75 | 3,237 | 277,573 | 74,498 | 71.3 K to 74.5 K (+4.54 %) |
Dec 15 2015 | ALXN | ALEXION PHARMACEUT ... | NORBY R DOUGLAS | Director | Grant | A | 49.43 | 5,572 | 275,424 | 71,261 | 65.7 K to 71.3 K (+8.48 %) |
Dec 15 2015 | ALXN | ALEXION PHARMACEUT ... | NORBY R DOUGLAS | Director | Grant | A | 26.64 | 7,932 | 211,308 | 65,689 | 57.8 K to 65.7 K (+13.73 %) |
Dec 15 2015 | ALXN | ALEXION PHARMACEUT ... | NORBY R DOUGLAS | Director | Grant | A | 16.83 | 12,276 | 206,605 | 57,757 | 45.5 K to 57.8 K (+26.99 %) |
Dec 15 2015 | ALXN | ALEXION PHARMACEUT ... | NORBY R DOUGLAS | Director | Grant | A | 18.01 | 13,000 | 234,130 | 45,481 | 32.5 K to 45.5 K (+40.02 %) |
May 08 2015 | ALXN | ALEXION PHARMACEUT ... | NORBY R DOUGLAS | Director | Option Exercise | A | 155.01 | 2,343 | 363,188 | 2,343 | |
May 08 2015 | ALXN | ALEXION PHARMACEUT ... | NORBY R DOUGLAS | Director | Grant | A | 0.00 | 700 | 0 | 32,481 | 31.8 K to 32.5 K (+2.20 %) |
May 07 2014 | ALXN | ALEXION PHARMACEUT ... | NORBY R DOUGLAS | Director | Option Exercise | A | 159.70 | 2,785 | 444,765 | 2,785 | |
Mar 04 2014 | ALXN | ALEXION PHARMACEUT ... | NORBY R DOUGLAS | Director | Grant | A | 0.00 | 895 | 0 | 32,676 | 31.8 K to 32.7 K (+2.82 %) |
Oct 30 2013 | ALXN | ALEXION PHARMACEUT ... | NORBY R DOUGLAS | Director | Gift | G | 0.00 | 24,363 | 0 | 31,781 | 56.1 K to 31.8 K (-43.39 %) |
May 23 2013 | ALXN | ALEXION PHARMACEUT ... | NORBY R DOUGLAS | Director | Option Exercise | M | 18.01 | 17,000 | 306,170 | 13,000 | |
May 23 2013 | ALXN | ALEXION PHARMACEUT ... | NORBY R DOUGLAS | Director | Option Exercise | M | 10.84 | 23,000 | 249,320 | 0 | |
May 23 2013 | ALXN | ALEXION PHARMACEUT ... | NORBY R DOUGLAS | Director | Sell | S | 100.11 | 11,186 | 1,119,830 | 56,144 | 67.3 K to 56.1 K (-16.61 %) |
May 23 2013 | ALXN | ALEXION PHARMACEUT ... | NORBY R DOUGLAS | Director | Sell | S | 102.59 | 4,610 | 472,940 | 67,330 | 71.9 K to 67.3 K (-6.41 %) |
May 23 2013 | ALXN | ALEXION PHARMACEUT ... | NORBY R DOUGLAS | Director | Sell | S | 104.03 | 24,204 | 2,517,942 | 71,940 | 96.1 K to 71.9 K (-25.17 %) |
May 23 2013 | ALXN | ALEXION PHARMACEUT ... | NORBY R DOUGLAS | Director | Buy | M | 18.01 | 17,000 | 306,170 | 96,144 | 79.1 K to 96.1 K (+21.48 %) |
May 23 2013 | ALXN | ALEXION PHARMACEUT ... | NORBY R DOUGLAS | Director | Buy | M | 10.84 | 23,000 | 249,320 | 79,144 | 56.1 K to 79.1 K (+40.97 %) |
May 09 2013 | ALXN | ALEXION PHARMACEUT ... | NORBY R DOUGLAS | Director | Option Exercise | A | 96.35 | 3,425 | 329,999 | 3,425 | |
Feb 08 2013 | ALXN | ALEXION PHARMACEUT ... | NORBY R DOUGLAS | Director | Grant | A | 0.00 | 2,471 | 0 | 56,144 | 53.7 K to 56.1 K (+4.60 %) |
May 09 2012 | ALXN | ALEXION PHARMACEUT ... | NORBY R DOUGLAS | Director | Option Exercise | A | 85.75 | 3,237 | 277,573 | 3,237 | |
Mar 12 2012 | ALXN | ALEXION PHARMACEUT ... | NORBY R DOUGLAS | Director | Option Exercise | M | 8.18 | 28,300 | 231,494 | 0 | |
Mar 12 2012 | ALXN | ALEXION PHARMACEUT ... | NORBY R DOUGLAS | Director | Option Exercise | M | 8.18 | 1,700 | 13,906 | 28,300 | |
Mar 12 2012 | ALXN | ALEXION PHARMACEUT ... | NORBY R DOUGLAS | Director | Buy | S | 85.01 | 28,300 | 2,405,783 | 30,743 | 2.4 K to 30.7 K (+1,158.41 %) |
Mar 12 2012 | ALXN | ALEXION PHARMACEUT ... | NORBY R DOUGLAS | Director | Buy | M | 8.18 | 28,300 | 231,494 | 59,043 | 30.7 K to 59 K (+92.05 %) |
Mar 12 2012 | ALXN | ALEXION PHARMACEUT ... | NORBY R DOUGLAS | Director | Sell | S | 85.00 | 1,700 | 144,500 | 30,743 | 32.4 K to 30.7 K (-5.24 %) |
Mar 12 2012 | ALXN | ALEXION PHARMACEUT ... | NORBY R DOUGLAS | Director | Buy | M | 8.18 | 1,700 | 13,906 | 32,443 | 30.7 K to 32.4 K (+5.53 %) |
May 13 2011 | ALXN | ALEXION PHARMACEUT ... | NORBY R DOUGLAS | Director | Option Exercise | A | 98.86 | 2,786 | 275,424 | 2,786 | |
Jan 18 2007 | ALXN | ALEXION PHARMACEUT ... | NORBY R DOUGLAS | Director | Grant | A | 0.00 | 2,000 | 0 | 4,000 | 2 K to 4 K (+100.00 %) |
Dec 17 2003 | ALXN | ALEXION PHARMACEUT ... | NORBY R DOUGLAS | Director | Option Exercise | A | 17.05 | 7,500 | 127,875 | 7,500 |
Page: 1